Meniere's disease (MD) is a heterogeneous, rare inner ear disorder characterized by recurrent vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. Its molecular mechanisms remain unclear due to significant clinical and immunological heterogeneity. In this study, we integrated multi‑omics genetic data to systematically screen for palmitoylation regulatory genes associated with MD risk....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is early-stage molecular research in an animal or cellular model; findings require substantial further validation before informing clinical practice.
Identifying a genetic regulator of immune activity in Ménière's disease advances the understanding of its poorly characterized autoimmune mechanisms, potentially opening new therapeutic targets.
- 01ZDHHC5 is a gene investigated for its role in regulating NKT (natural killer T) cell function.
- 02NKT cells are a type of immune cell that may contribute to inner-ear inflammation in Ménière's disease.
- 03Ménière's disease involves recurrent vertigo, sensorineural hearing loss, tinnitus, and ear fullness.
- 04Published in Mammalian Genome (DOI: 10.1007/s00335-026-10264-x); PMID 42595917.
- 05Findings are preliminary and do not yet translate to a change in clinical management.
ZDHHC5 may regulate NKT cell function and the immune response in Ménière's disease.
studypartially supportedImmune dysregulation involving NKT cells may contribute to the pathophysiology of Ménière's disease.
studypartially supported- PMID
- 42595917
- DOI
- 10.1007/s00335-026-10264-x.
- Journal
- Mammalian Genome
- Publication type
- research_article
- Evidence level
- 4
- Population
- Molecular/genetic model investigating NKT cell immune activity relevant to Ménière's disease
- Intervention
- Investigation of ZDHHC5 gene expression and its regulation of NKT cell function
Primary outcomes
ZDHHC5 regulation of NKT cell function; Characterisation of immune response mechanisms in Ménière's disease